Monographie - Neostigmine methylsulfate

Ultimo aggiornamento :
19/11/2024

Neostigmine methylsulfate

Struttura chimica

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Adwigmine	Egitto
Amostigmine	Egitto
Beemine	India
Bloxiverz
Epistigmine	Egitto
Fadastigmina	Argentina, Italia, Portogallo
Ipostigmine	Iran
Miostin	Romania
Neostig	Germania
Neostigmin	Germania, Svezia
Neostigmina	Argentina, Chile, Colombia, Ecuador, Perù, Portogallo, Spagna, Venezuela
Neostigmine	Arabia Saudita, Australia, Canada, Egitto, Gran Bretagna, Grecia, Irlanda, Malaysia, nuova Zelanda, Paesi Bassi, Turchia
Neostigmine methylsulfate	Canada
Neostigten	Perù
Normastigmin	Austria
Planstigmin	Turchia
Polstigminum	Polonia
Prostigmin	Austria, Belgio, Grecia, Malaysia, Paesi Bassi, Svizzera
Prostigmina	Italia
Prostigmine	Belgio, Chile, Colombia, Egitto, Emirati Arabi Uniti, Francia, Lussemburgo, Marocco, Messico, Spagna, Venezuela
Setisin	Malaysia
Stigmosan	Ungheria
Tigmin	Perù
Visulmin	Messico

Bibliografia : Neostigmine methylsulfate

	tipo	pubblicazione
815	Rivista	Stewart JT, Warren FW, King DT, Venkateshwaran TG, Fox JL. Stability of ondansetron hydrochloride and 12 medications in plastic syringes. Am J Health-Syst Pharm 1998 ; 55: 2630-2634.
1200	Rivista	Chaudry IA, Bruey KP, Hurlburt LE, Oden EM. Compatibility of netilmycin sulfate injection with commonly used intravenous injections and additives. Am J Hosp Pharm 1981 ; 38: 1737-1742.
1228	Rivista	Allen LV, Stiles ML. Compatibility of various admixtures at Y-injection sites of intravenous administration sets. Part2. Am J Hosp Pharm 1981 ; 38: 380-381.
1682	Rivista	Storms M, Stewart JT, Warren FW. Stability of neostigmine methylsulfate injection at ambient temperature and 4°C in polypropylene syringes. Int J Pharm Compound 2002 ; 6: 475-477.
2286	Rivista	Ben M, Trusley C, Kupiec TC, Trissel LA. Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated Y-site administration. Int J Pharm Compound 2008 ; 12, 4: 368-371.
2291	Rivista	Yeh MK. Degradation kinetics of neostigmine in solution. Drug Dev Ind Pharm 2000 ; 26, 11: 1221-1226.
3372	Rivista	Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3578	Laboratorio	Cisplatin - Summary of Product Characteristics Accord Healthcare 2011
3599	Laboratorio	Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics Amco Amdipharm Mercry 2013
3644	Laboratorio	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010

Mentions Légales